Subscribe
Facebook Twitter Instagram Youtube

Swiss Hepatitis C Association

Email

info@hepc.ch

Phone

077 467 35 71

Web

http://ww.hepc.ch

Address

Mäderenweg 17, SHCV Oberglatt 8154 Switzerland
About Swiss Hepatitis C Association

Background

The Swiss Hepatitis association maintains a competence network on viral Hepatitis with a focus on public health. The non-profit organisation comments on issues in the field of viral Hepatitis and carries out its own projects. Its board members represent the various subject areas and academic disciplines concerning themselves with or being affected by viral Hepatitis. Since 2017 Swiss Hepatitis replaces the organisation Swiss Experts in Viral Hepatitis (SEVHep) and continues its activities. 

Goals

Our main goal is to build a network of knowledge and competence in Switzerland in the area of viral hepatitis, focusing on public health aspects.

Our key objectives are:

  • to develop implement and integrate a strategy to eliminate viral Hepatitis in Switzerland,
  • to maintain the Swiss Hepatitis Strategy network,
  • establish and maintain scientific relations with those involved in diagnostics and treatment of viral hepatitis as well as the vaccine developing industry, and
  • keep the information platform www.hepatitis-switzerland.ch running and up-to-date.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)
Confirm consent(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close